Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ovosiston

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Subjective side effects affect the acceptance of antiovulation drugs although they are fairly harmless from a pathological… Expand
1975
1975
During hormonal contraception with Deposiston (once a week pill) and with Sequenz-Ovosiston (14 days mestranol 0.1 mg, 7 days… Expand
1974
1974
Clinical experiences with the use of Ovosiston in the treatment of hirsutism in 44 women are reported. Ovosiston was given as… Expand
1974
1974
Blood glucose levels were studied during an insulin tolerance test in 18 healthy, non-diabetic women treated with Ovosiston for… Expand
1972
1972
26 women using Ovosiston as a contraceptive and 22 women using it as a therapeutic agent were administered thromboelastograms… Expand
1970
1970
Reaction times were measured in 235 women taking Ovosiston (.1 mg mestranol and 3 mg chlormadinone acetate) and in 200 controls… Expand
1970
1970
Ovosiston (3 mg chlormadinone acetate and .1 mg mestranol 21 combined tablets) was precribed for 1315 women for 9095 cycles… Expand
1970
1970
The effects of Ovosiston (mestranol and chlormadinone) and of chlorm adinone on endometrial histology and histochemistry were… Expand
Review
1970
Review
1970
2 reports showing higher incidence of breakthrough bleeding and spotting with the new lower dose Ovosiston (.08 mg mestranol and… Expand
1969
1969
The effects of Ovosiston (3 mg chlormadinone acetate, .1 mg mestranol) on the endometrium were studied in 100 women with normal… Expand